Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
2025 Standout
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
Works of Steve Pascoe being referenced
The effect of exacerbation history on outcomes in the IMPACT trial
2020
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Steve Pascoe | 617 | 326 | 1 | 134 | 10 | 678 | |
| S.C. Erzurum | 424 | 370 | 3 | 101 | 10 | 656 | |
| Samuel M. Aguayo | 410 | 111 | 21 | 18 | 582 | ||
| A Pelletier | 511 | 95 | 70 | 14 | 622 | ||
| Suzanne Maahs | 119 | 127 | 351 | 7 | 611 | ||
| Kiran Bhirangi | 353 | 203 | 198 | 19 | 699 | ||
| Margrét B. Andrésdóttir | 177 | 101 | 2 | 125 | 20 | 734 | |
| G. Stähler | 552 | 149 | 114 | 16 | 635 | ||
| Tim Oates | 499 | 550 | 1 | 14 | 6 | 784 | |
| Diana Reyes-Garau | 411 | 235 | 28 | 17 | 821 | ||
| Helen Lovell | 139 | 72 | 45 | 8 | 823 |
All Works
Loading papers...